Arianna Goracci
Overview
Explore the profile of Arianna Goracci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cuomo A, Santucci A, Chioccioli M, Goracci A, Bolognesi S, Fagiolini A
Prim Care Companion CNS Disord
. 2022 Jun;
24(3).
PMID: 35687882
To evaluate the effectiveness and tolerability of vortioxetine at supratherapeutic dosages in patients with treatment-resistant depression. A retrospective observational naturalistic study was conducted in 56 depressed patients resistant to standard...
12.
Mineo L, Rodolico A, Spedicato G, Aguglia A, Bolognesi S, Concerto C, et al.
Eur Psychiatry
. 2022 May;
65(1):e30.
PMID: 35638732
Background: Subthreshold hypomania during a major depressive episode challenges the bipolar-unipolar dichotomy. In our study we employed a cross-diagnostic cluster analysis - to identify distinct subgroups within a cohort of...
13.
Cuomo A, Koukouna D, Spiti A, Barilla G, Goracci A, Bolognesi S, et al.
Front Psychiatry
. 2021 Dec;
12:803034.
PMID: 34970174
Compared to the general population, people with severe mental illness (SMI) have a poorer health status and a higher mortality rate, with a 10-20-year reduction in life expectancy. Excess mortality...
14.
Mineo L, Rodolico A, Spedicato G, Aguglia A, Bolognesi S, Concerto C, et al.
Bipolar Disord
. 2021 Nov;
24(5):530-538.
PMID: 34846773
Background: The criteria of the Diagnostic and Statistical Manual of Mental Disorders 5th edition "with mixed features specifier" (DSM-5 MFS) are considered controversial since they include only typical manic symptoms....
15.
Carmassi C, DellOste V, Bui E, Foghi C, Bertelloni C, Rita Atti A, et al.
J Affect Disord
. 2021 Nov;
298(Pt A):209-216.
PMID: 34728285
Background: Healthcare workers (HCWs) deployed to the frontline during the COVID-19 pandemic are at risk for developing mental disorders, with a possible impact on their wellbeing and functioning. The present...
16.
Aguglia A, Cuomo A, Amerio A, Bolognesi S, Salvo G, Fusar-Poli L, et al.
Int J Psychiatry Clin Pract
. 2021 Jan;
25(1):73-81.
PMID: 33399494
Objective: The aims of this study were to assess the impact of seasonal pattern on several clinical dimensions in inpatients with a current major depressive episode and to evaluate clinical...
17.
Cuomo A, Beccarini Crescenzi B, Bolognesi S, Goracci A, Koukouna D, Rossi R, et al.
Ann Gen Psychiatry
. 2020 Sep;
19:50.
PMID: 32939220
Background: Major depressive disorder (MDD) is a recurrent illness with high rates of chronicity, treatment-resistance, and significant economic impact. -Adenosylmethionine (SAMe), a molecule that is formed naturally in the human...
18.
Amodeo G, Laurenzi P, Santucci A, Cuomo A, Bolognesi S, Goracci A, et al.
Expert Opin Pharmacother
. 2020 Jun;
21(14):1685-1698.
PMID: 32584616
: Postpartum depressive disorder (PPD) is a burdensome medical condition. To date, only one treatment (Brexanolone) has undergone registrational trials and is approved in the United States with an indication...
19.
Onat O, Kars M, Gul S, Bilguvar K, Wu Y, Ozhan A, et al.
J Clin Invest
. 2020 Jun;
130(7):3885-3900.
PMID: 32538895
Attention deficit/hyperactivity disorder (ADHD) is a common and heritable phenotype frequently accompanied by insomnia, anxiety, and depression. Here, using a reverse phenotyping approach, we report heterozygous coding variations in the...
20.
Fagiolini A, Bolognesi S, Goracci A, Beccarini Crescenzi B, Cuomo A
Riv Psichiatr
. 2020 Apr;
54(6):1-6.
PMID: 32310932
Cariprazina {RGH-188; trans-N- [4- [2- [4- (2,3-diclorofenil) piperazin-1-il] etil] cicloesil] -N_, N_-dimetilurea cloridrato} è un antipsicotico atipico di nuova generazione, con un originale profilo farmacodinamico e farmacocinetico. Cariprazina ha due...